HeartBeam 

$0.09
46
-$0.03-25% Today

Statistics

Day High
0.12
Day Low
0.12
52W High
0.12
52W Low
0.12
Volume
18
Avg. Volume
-
Mkt Cap
3.1M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

7MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.19
-0.17
-0.15
-0.13
Expected EPS
-0.140583
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-38.9MNet Income

Analyst Ratings

$5.63Average Price Target
The highest estimate is 8.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BEATW. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories offers a broad range of medical devices, including cardiovascular devices, competing directly with HeartBeam's heart monitoring technologies.
Medtronic
MDT
Mkt Cap111.22B
Medtronic plc specializes in medical technologies, services, and solutions, including cardiac and vascular devices, making it a direct competitor in the heart monitoring space.
Boston Scientific
BSX
Mkt Cap93.36B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, including cardiac rhythm management.
Koninklijke Philips N.V.
PHG
Mkt Cap25.99B
Royal Philips offers healthcare solutions including advanced cardiac diagnostics and monitoring technologies, competing in the same space as HeartBeam.
Hologic
HOLX
Mkt Cap16.89B
Hologic, Inc. focuses on women's health and well-being through early detection and treatment, including cardiac health, positioning it as a competitor.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. provides a range of clinical diagnostics and life science research products, including those for cardiovascular disease detection.
GE Aerospace
GE
Mkt Cap296.57B
General Electric Company, through its healthcare division, offers medical imaging and monitoring technologies, including those for cardiac care.
Siemens
SIEGY
Mkt Cap189.36B
Siemens Healthineers AG is a major player in the healthcare industry, offering a wide range of medical technologies, including diagnostic and therapeutic solutions for cardiac conditions.
Masimo
MASI
Mkt Cap9.59B
Masimo Corporation is known for its innovative noninvasive monitoring technologies, including pulse oximetry, which can be used in cardiac care.
Resmed
RMD
Mkt Cap32.71B
ResMed Inc. specializes in cloud-connectable medical devices for respiratory disorders but also offers products that can be used in cardiac patient monitoring.

About

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.
Show more...
CEO
Employees
15
Country
US
ISIN
US42238H1169

Listings

0 Comments

Share your thoughts

FAQ

What is HeartBeam stock price today?
The current price of BEATW is $0.09 USD — it has decreased by -25% in the past 24 hours. Watch HeartBeam stock price performance more closely on the chart.
What is HeartBeam stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange HeartBeam stocks are traded under the ticker BEATW.
Is HeartBeam stock price growing?
BEATW stock has fallen by -25.06% compared to the previous week, the month change is a -45.26% fall, over the last year HeartBeam has showed a -80% decrease.
What is HeartBeam market cap?
Today HeartBeam has the market capitalization of 3.1M
When is the next HeartBeam earnings date?
HeartBeam is going to release the next earnings report on May 07, 2026.
What were HeartBeam earnings last quarter?
BEATW earnings for the last quarter are -0.14 USD per share, whereas the estimation was -0.14 USD resulting in a -1.82% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is HeartBeam revenue for the last year?
HeartBeam revenue for the last year amounts to 0 USD.
What is HeartBeam net income for the last year?
BEATW net income for the last year is -38.9M USD.
How many employees does HeartBeam have?
As of April 07, 2026, the company has 15 employees.
In which sector is HeartBeam located?
HeartBeam operates in the Health Care sector.
When did HeartBeam complete a stock split?
HeartBeam has not had any recent stock splits.